Home›Linezolid›Linezolid + Tapentadol Hydrochloride

Does Linezolid Interact with Tapentadol Hydrochloride?

The NUCYNTA label names linezolid as a monoamine oxidase inhibitor. It warns of serotonin syndrome or opioid toxicity with MAOI interactions and contraindicates NUCYNTA during MAOI use or within the preceding 14 days.

Label evidence and limitations

Named-drug label evidence. The label’s contraindication supports a strong warning for the specified product. Patients should ask their prescriber or pharmacist about their medicines rather than adjust treatment themselves.

Product scope: NUCYNTA oral tapentadol tablets.

Read the DailyMed label: These highlights do not include all the information needed to use NUCYNTA ® TABLETS safely and effectively. See full prescribing information for NUCYNTA ® TABLETS. NUCYNTA ® (tapentadol) tablets for oral use C-II Initial U.S. Approval: 2008
Section: 7 Drug Interactions — Monoamine Oxidase Inhibitors. Compared version 7, label date 2025-12-30. The linked label may be updated after this comparison.

This comparison uses the label identifier saved with the CDI record. The compared version may be newer than the original extraction.

AI-assisted source comparison dated 2026-10-16. This is a comparison of label text, not independent clinical review or an individual safety assessment. CDI's stored severity category is not an FDA-assigned rating. Confirm your exact medicines and formulations with your pharmacist or prescriber before changing treatment.

Stored CDI classification
Contraindicated
Linezolid Class
Oxazolidinone Antibacterial
Management
Confirm exact products with your pharmacist
Data Source
Product label via NLM DailyMed

What To Tell Your Doctor or Pharmacist

If you are taking Linezolid and your doctor is considering prescribing Tapentadol Hydrochloride (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Linezolid(Zyvox)+💊 Tapentadol Hydrochloride(Tapentadol)

Severity & Interaction Details

⛔
Stored CDI classification: contraindicated
Named-drug label evidence
The label’s contraindication supports a strong warning for the specified product. Patients should ask their prescriber or pharmacist about their medicines rather than adjust treatment themselves.
Stored CDI scale
MinorContra
On record
Yes
Drug A class
Oxazolidinone Antibacterial
Drug B class
—
Source
NLP:tapentadol hydrochloride

How to interpret this source comparison

The label’s contraindication supports a strong warning for the specified product. Patients should ask their prescriber or pharmacist about their medicines rather than adjust treatment themselves.

About Linezolid and Tapentadol Hydrochloride

Linezolid is an Oxazolidinone Antibacterial. Linezolid is also sold under the brand name Zyvox. Tapentadol Hydrochloride additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:tapentadol hydrochloride

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Linezolid and Tapentadol Hydrochloride against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations